Product Theaters
Welcome to the digital edition of AAPA 2020’s Product Theaters! These free videos provide you with an opportunity to learn about some of the newest product technologies and advances. Get firsthand information straight from industry experts.
To get started, select a session and log into Learning Central to view the video.
|
The Burden of COPD Exacerbations
Speaker: Nicole Alvarez, PA-C, MS | Presented by: AstraZeneca Pharmaceuticals, LP Discuss how exacerbations can drive a cascade of further events, disease progression, and increased mortality. |
|
|
Clinical Considerations Across the Spectrum of Coronary Artery Disease
Speaker: John Venditto, MD, MBA, FACC | Presented by: AstraZeneca Pharmaceuticals, LP Discuss clinical considerations across the spectrum of coronary artery disease. |
|
|
Thinking Beyond Glycemia: The Importance of Managing Heart Failure Risks in Type 2 Diabetes
Speaker: Susan Symington, MPAS, PA-C, DFAAPA | Presented by: AstraZeneca Pharmaceuticals, LP Discuss the association of T2D and HF. |
|
|
Heart Failure and Delivering Value-based Care
Speaker: Nihar R. Desai, MD, MPH | Presented by: Novartis Pharmaceuticals Corporation A disease state educational presentation focusing on the interplay between optimizing heart failure care and quality and performance measures. |
|
Clinical Insights in VTE: Treatment and Risk Reduction Through Prophylaxis
Speaker: Matthew Schultz, PA-C | Presented by: Janssen Pharmaceuticals, Inc. Join us on July 22nd to discuss Clinical Insights in VTE: Treatment and Risk Reduction Through Prophylaxis. |
|
|
Enabling Telemedicine and Remote Monitoring With the FreeStyle Libre 14 day System
Speaker: Daniel Einhorn, MD, FACP, FACE | Presented by: Abbott Diabetes Care Join us to learn about the #1 CGM worldwide† used by more than 2 million people*, the FreeStyle Libre 14 day system. |
|
|
First-Choice Therapy for HFrEF: Meeting the Burden of Proof
Speaker: Shannon P. Marsh, PA-C | Presented by: Novartis Pharmaceuticals Corporation Regardless of your patients’ previous HF treatment history, following this program you can feel confident selecting your first-choice therapy for your patients with HFrEF. |
|
|
Resident With Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis
Speaker: Dana Saffel, PharmD | Presented by: ACADIA Pharmaceuticals Inc Discuss educational information about hallucinations and delusions associated with Parkinson’s disease (PD) psychosis. Review the clinical efficacy data and safety profile on a treatment option. |
Please note: Because the supporting company determines the content of these special sessions, these presentations are not eligible or approved for CME credit.